Behavioral prevention of HBV transmission in urban communities toward global elimination of hepatitis in 2030: a systematic review

Submitted: 12 November 2023
Accepted: 16 March 2024
Published: 16 April 2024
Abstract Views: 441
PDF: 167
Supplementary Materials: 14
HTML: 4
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Hepatitis B is a serious threat to public health on a global scale. The Hepatitis B virus (HBV), which spreads both vertically and horizontally, is easily contracted by anyone. In 2020, the World Health Organization estimates that 257 million people worldwide have hepatitis B, and 900,000 people die from it each year. According to the World Health Organization (2021), there are approximately 39.4 million people in Southeast Asia living with chronic hepatitis B mortality, with 410,000 deaths caused by the disease.  HBV can spread through injections, horizontal transmission, blood transfusions, and organ transplants. Cochrane, Science Direct, PubMed, Elsevier, Sage, Willey, DOAJ, and Google Scholar database sources were used to search for supported research on how to prevent hepatitis virus transmission in urban communities. 15 publications address the primary and secondary prevention of hepatitis B transmission in urban settings. Prevention keeps a person in good health and prevents them from progressing to a later, worse stage. Given that the hepatitis B virus can infect anyone, regardless of age, and that it affects people's health worldwide, as well as their families, communities, and families within them. In order to eradicate the hepatitis B virus, society must be aware of the importance of implementing preventive measures on a continuous and long-term basis through health advocacy activities, hepatitis B virus screening campaigns, health education, counseling, hepatitis B vaccination with community-based activities, and secondary prevention through combination therapy treatment in post-liver transplant patients.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Deng X, Liu D, Delcourt MP, et al. No hepatitis delta virus seropositivity among blood donors with overt and occult hepatitis B infection in Dalian, Liaoning Province, China. Viruses 2023;15:1509. DOI: https://doi.org/10.3390/v15071509
Diniarti F, Rohani T, Prasentya W. Faktor-Faktor yang Mempengaruhi Kejadian Hepatitis B pada Ibu Hamil. Jurnal riset kesehatan poltekkes depkes bandung 2022;14:197-205. DOI: https://doi.org/10.34011/juriskesbdg.v14i1.1971
Nlinwe NO, Lungle D. Risk factors associated with hepatitis B virus infection among pregnant women attending the antenatal care unit of the Bamenda Regional Hospital. Public Health Practice 2021;2:100160. DOI: https://doi.org/10.1016/j.puhip.2021.100160
Olaru ID, Meier MB, Mirzayev F, et al. Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease: systematic review and meta-analysis. Eclinicalmedicine 2023;58. DOI: https://doi.org/10.1016/j.eclinm.2023.101938
Raslan E, AbdAllah M, Soliman S. The prevalence and determinants of hepatitis B among Egyptian adults: a further analysis of a country-representative survey. Egyptian Liver J 2022;12:46. DOI: https://doi.org/10.1186/s43066-022-00207-x
Khan A, Hussain G, Zahri M, Zaman G, Wannasingha Humphries U. A stochastic SACR epidemic model for HBV transmission. J Biological Dynamics 2020;14:788-801. DOI: https://doi.org/10.1080/17513758.2020.1833993
Riskesdas LN. Indonesian Ministry of Health, Health Research and Development Agency. 2018
Kementerian Kesehatan, Indonesian Health Profile. Kementerian kesehatan Indonesia: Jakarta. 2021
Muljono DH, Wijayadi T, Sjahril R. Hepatitis B virus infection among health care workers in Indonesia. Euroas J Hepato-Gastroenterol 2018;8:88. DOI: https://doi.org/10.5005/jp-journals-10018-1269
Luo Y, Dong Z, Qi S. Application of health education model based on theory of behavior change in nursing care of patients with chronic hepatitis B. J Nanomat 2022;2022. DOI: https://doi.org/10.1155/2022/1982554
Hidayah AN, Afridah W. Literature Review: Faktor Penyebab Hepatitis B Pada Ibu Hamil. Jurnal Multidisiplin Indonesia 2023;2:443-50. DOI: https://doi.org/10.58344/jmi.v2i3.180
Khalid FK, Rasheed NA, Hussein NR, Naqid IA. A study of HBV infection and its risk factors in pregnant women in Zakho city, Iraq. PloS One 2022;17:e0273362. DOI: https://doi.org/10.1371/journal.pone.0273362
Liu D, Liu Y, Ni J, et al. Hepatitis B infection among pregnant women in China: a systematic review and meta-analysis. Frontiers Public Health 2022;10:879289. DOI: https://doi.org/10.3389/fpubh.2022.879289
Chen Z, Zeng M, Liu D, et al. Antenatal administration of hepatitis B immunoglobulin and hepatitis B vaccine to prevent mother to child transmission in hepatitis B virus surface antigen positive pregnant women: A systematic review and meta-analysis. Medicine 2020;99. DOI: https://doi.org/10.1097/MD.0000000000019886
Aladag H, Aladag M. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?. Eur Rev Med Pharmacol Sci 2023;27.
Hoo CZ, WZ WA, Omar H, Tan SS. Prevention of mother-to-child transmission of hepatitis B virus: An observation of routine practice in a tertiary liver centre before and after the introduction of the global health sector strategy on viral hepatitis. Med J Malaysia 2023;78:234-40.
Dwiartama A, Nirbayati WF, Giri-Rachman EA, et al. Knowledge, attitude, and practice towards hepatitis B infection prevention and screening among Indonesians. Int J Environ Res Public Health 2022;19:4644. DOI: https://doi.org/10.3390/ijerph19084644
Hyun CS, Ko O, Lee S, McMenamin J. Long term outcome of a community-based hepatitis B awareness campaign: eight-year follow-up on linkage to care (LTC) in HBV infected individuals. BMC Infect Dis 2019;19:1-8. DOI: https://doi.org/10.1186/s12879-019-4283-x
Wu Z, Bao H, Yao J, et al. Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis. Human Vaccines & Immunotherapeutics 2019;15:220-7. DOI: https://doi.org/10.1080/21645515.2018.1509172
Abdullahi LH, Kagina BM, Ndze VN, et al. Improving vaccination uptake among adolescents. Cochrane Database of Systematic Reviews 2020;1:CD011895. DOI: https://doi.org/10.1002/14651858.CD011895.pub2
Freeland C, Bodor S, Perera U, Cohen C. Barriers to hepatitis B screening and prevention for African immigrant populations in the United States: A qualitative study. Viruses 2020;12:305. DOI: https://doi.org/10.3390/v12030305
Nguyen MH, Wong G, Gane E, et al. Hepatitis B virus: advances in prevention, diagnosis, and therapy. Clin Microbiol Rev 2020;33:10-128. DOI: https://doi.org/10.1128/CMR.00046-19
Zhang X, Guan L, Tian H, et al. Risk factors and prevention of viral hepatitis-related hepatocellular carcinoma. Front Oncol 2021;11:686962. DOI: https://doi.org/10.3389/fonc.2021.686962
Maamor NH, Muhamad NA, Mohd Dali NS, et al. Seroprevalence of hepatitis B among healthcare workers in Asia and Africa and its association with their knowledge and awareness: a systematic review and meta-analysis. Front Public Health 2022;10:859350. DOI: https://doi.org/10.3389/fpubh.2022.859350
Mauss S, Berg T, Rockstroh J, et al. Hepatology–a clinical textbook, 20th. 2020.
Sonderup MW, Spearman CW. Global disparities in hepatitis B elimination—a focus on Africa. Viruses 2022;14:82. DOI: https://doi.org/10.3390/v14010082
World Health Organization. Global Health Sector Strategies on Viral Hepatitis 2016-2021. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_32-en.pdf?ua=1
World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. World Health Organization; 2016. https://iris.who.int/bitstream/handle/10665/246177/who?sequence=1
Eleje GU, Onubogu CU, Fiebai PO, et al. Mother-to-child transmission of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among pregnant women with single, dual or triplex infections of human immunodeficiency virus, hepatitis B virus and hepatitis C virus in Nigeria: a systematic review and meta-analysis. SAGE Open Med 2022;10:20503121221095411. DOI: https://doi.org/10.1177/20503121221095411
Rockett IR, Putnam SL, Jia H, et al. Unmet substance abuse treatment need, health services utilization, and cost: a population-based emergency department study. Ann Emerg Med 2005;45:118-27. DOI: https://doi.org/10.1016/j.annemergmed.2004.08.003
Hamilton EM, Rassam W, Yan Y, et al. Correlates of chronic hepatitis B virus infection in the general adult population of China: Systematic review and meta‐analysis. J Viral Hepat 2023; https://doi.org/10.1111/jvh.13816 DOI: https://doi.org/10.1111/jvh.13816
Yim HJ, Kim JH, Cho YK, et al. Non-inferior efficacy of tenofovir disoproxil to tenofovir disoproxil fumarate in virologically suppressed chronic hepatitis B patients. Drug Des Devel Therapy 2022:3263-74. DOI: https://doi.org/10.2147/DDDT.S376821
Patterson J, Abdullahi L, Hussey GD, et al. A systematic review of the epidemiology of hepatitis A in Africa. BMC Infect Dis 2019;19:1-5. DOI: https://doi.org/10.1186/s12879-019-4235-5
Machmud PB, Führer A, Gottschick C, Mikolajczyk R. Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study. Vaccines 2023;11:398. DOI: https://doi.org/10.3390/vaccines11020398
Périères L, Diallo A, Marcellin F, et al. Hepatitis B in Senegal: a successful infant vaccination program but urgent need to scale up screening and treatment (ANRS 12356 AmBASS survey). Hepatology Comm 2022;6:1005-15. DOI: https://doi.org/10.1002/hep4.1879
Smathers SA, Sammons JS. A strategy for expanding infection prevention resources to support organizational growth. Am J Infect Control 2020;48:975-81. DOI: https://doi.org/10.1016/j.ajic.2020.04.008
Wang X, Zhang Y, Ben Y, et al. Anti-HBc IgG responses occurring at the early phase of infection correlate negatively with HBV replication in a mouse model. Viruses 2022;14:2011. DOI: https://doi.org/10.3390/v14092011
Banik S, Datta A, Ghosh A, et al. The prevalence of hepatitis B virus infection in Bangladesh: A systematic review and meta-analysis. Epidemiol Infect 2022;150:e47. DOI: https://doi.org/10.1017/S0950268822000061
Yotsuyanagi H, Kurosaki M, Yatsuhashi H, et al. Characteristics and healthcare costs in the aging hepatitis B population of Japan: a nationwide real-world analysis. Digest Dis 2022;40:68-77. DOI: https://doi.org/10.1159/000515854
Belopolskaya M, Avrutin V, Kalinina O, et al. Chronic hepatitis B in pregnant women: Current trends and approaches. World J Gastroenterol 2021;27:3279. DOI: https://doi.org/10.3748/wjg.v27.i23.3279
Bierhoff M, Hashmi AH, Pateekhum C, et al. A mixed-methods evaluation of hepatitis B knowledge, attitudes, and practices among migrant women in Thailand. BMC Pregnancy Childbirth 2021;21:1-2. DOI: https://doi.org/10.1186/s12884-021-03914-2
Ko K, Kim R, Nagashima S, et al. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia. BMC Infect Dis 2023;23:1-2. DOI: https://doi.org/10.1186/s12879-023-08249-1
Banafa AM, Edrees WH, Al-Falahi GH, Al-Shehari WA. Prevalence of hepatitis B surface antigen among orphans children living in orphanage in Sana'a city, Yemen. PSM Microbiol 2022;7:19-26.
Mugabiirwe N, Kalyetsi R, Ayella R, et al. Hepatitis B virus infection and HBeAg positivity among pregnant women in South West Uganda. Afr J Laboratory Med 2022;11:1-6. DOI: https://doi.org/10.4102/ajlm.v11i1.1784
Joseph Davey D, Hsiao NY, Wendy Spearman C, et al. Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out. BMC Infect Dis 2022;22:719. DOI: https://doi.org/10.1186/s12879-022-07697-5
Yusuf F, Abubakar A, Maghfirah D, Baswin A. Relationship red distribution width to platelet ratio with fibrosis degrees based on transient elastography in chronic hepatitis B patients. Bali Med J 2021;10:793-7. DOI: https://doi.org/10.15562/bmj.v10i2.2355
Komada K, Ichimura Y, Shimada M, et al. Impact of hepatitis B vaccination programs in Vietnam evaluated by estimating HBsAg prevalence. J Virus Erad 2022;8:100309. DOI: https://doi.org/10.1016/j.jve.2022.100309
Zheng S, Zhang H, Chen R, et al. Pregnancy complicated with hepatitis B virus infection and preterm birth: a retrospective cohort study. BMC Pregn Childbirth 2021;21:1-8. DOI: https://doi.org/10.1186/s12884-021-03978-0
Denando RK, Cahyati WH. Faktor Risiko Hepatitis B pada Ibu Hamil di Kota Semarang Tahun 2020-2021 (Studi Kasus di Puskesmas Genuk & Puskesmas Bangetayu). Jurnal Kesehatan Masyarakat 2022;10:656-65.
Ma T, Aw MM, Lee GH. Cost-effectiveness analysis of antiviral treatment for pregnant women with high viral load to prevent hepatitis B virus vertical transmission. Singapore Med J 2020;61:24. DOI: https://doi.org/10.11622/smedj.2019092
Hoang TT, Bui TT, Pham TT, et al. Study the correlation between the mother-to-child transmission risk factors in chronic hepatitis B virus infection pregnant women in vietnam by HCA method. Available from: https://doi.org/10.20944/preprints202208.0292.v1 DOI: https://doi.org/10.20944/preprints202208.0292.v1
Sirilert S, Tongsong T. Hepatitis B virus infection in pregnancy: immunological response, natural course and pregnancy outcomes. J Clin Medi 2021;10:2926. DOI: https://doi.org/10.3390/jcm10132926
Rajamoorthy Y, Taib NM, Mudatsir M, et al. Risk behaviours related to hepatitis B virus infection among adults in Malaysia: A cross-sectional household survey. Clin Epidemiol Global Health 2020;8:76-82. DOI: https://doi.org/10.1016/j.cegh.2019.04.011

How to Cite

Diniarti, F., Said, M. S. M., Rashid, N. A., & Poddar, S. (2024). Behavioral prevention of HBV transmission in urban communities toward global elimination of hepatitis in 2030: a systematic review. Healthcare in Low-Resource Settings, 12(2). https://doi.org/10.4081/hls.2024.12072

Similar Articles

You may also start an advanced similarity search for this article.